Merrimack Pharmaceuticals | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)
Merrimack Pharmaceuticals | 8-K: Current report
Merrimack Pharmaceuticals | DEFA14A: Others
Merrimack Pharmaceuticals | 8-K: Current report
Merrimack Pharmaceuticals | DEFA14A: Others
Merrimack Pharmaceuticals | 8-K: Current report
Merrimack Pharmaceuticals | DEFR14A: Definitive proxy statement in connection with contested solicitations
Merrimack Pharmaceuticals | DEFA14A: Others
Merrimack Pharmaceuticals | 8-K: Current report
Merrimack Pharmaceuticals | DEFA14A: Others
Merrimack Pharmaceuticals | DEF 14A: Definitive information statements
Merrimack Pharmaceuticals | 8-K: Current report
Merrimack Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Merrimack Pharmaceuticals | DEFA14A: Others
Merrimack Pharmaceuticals | 8-K: Current report
Merrimack Pharmaceuticals | 8-K: Merrimack Reports Third Quarter 2023 Financial Results
Merrimack Pharmaceuticals | 8-K: Merrimack Reports Second Quarter 2023 Financial Results
Merrimack Pharmaceuticals | 8-K: Current report
Merrimack Pharmaceuticals | 8-K: Merrimack Reports First Quarter 2023 Financial Results
Merrimack Pharmaceuticals | DEFA14A: Others
No Data